Baidu
map

加快中医药人才培养,各地纷纷放大招

2018-01-24 徐婧 中国中医

“致天下之治者在人才”,在岁月流转中,这一论断的正确性反复得到印证。中医药事业需要人才也孕育着人才,把中医药人才工作摆在更加突出的位置,也成为新时代中医药工作的重点。

“致天下之治者在人才”,在岁月流转中,这一论断的正确性反复得到印证。中医药事业需要人才也孕育着人才,把中医药人才工作摆在更加突出的位置,也成为新时代中医药工作的重点。

回顾2017年,展望2018年,各地响应国家号召,创新人才机制,改革人才评价体系,多举措促中医药优秀人才不断涌现。

“头雁效应”塑精英

湖北省率先将“岐黄工程”纳入发展规划,根据《国家中医药管理局办公室关于启动中医药传承与创新“百千万”人才工程(岐黄工程)2017年中医优秀人才项目的通知》,湖北省经组织申报、资格审核、省级遴选和国家选拔,确定了中医临床优秀人才和基础优秀人才。

湖北省卫生计生委副主任姚云说:“要发挥精英人才的‘头雁效应’,建设一支下得去、留得住、干得好的队伍。”

在长江以北,这样的遴选工作也在全面铺开,甘肃、宁夏已经完成第六批全国老中医药专家学术经验继承人员的遴选、推荐。甘肃省卫生计生委巡视员甘培尚说:“岐黄工程让2018年甘肃省的人才建设有了新气象。”

这一工程的部署实施,为打造精英中医药人才队伍奠定了基础,为选拔造就中医药领军人才,培养中青年中医药骨干人才,建设中医药传承与创新人才培养平台提供了动力。

中医药高层次人才建设的引擎已经加码,高层次的人才队伍将源源不断地输送到中医药事业中去。

中坚群体下基层

“在山东,大部分基层医生学历水平较低,优秀人才缺乏,这是目前山东省基层中医药工作面临的困境和短板。”山东省中医药管理局局长孙春玲说。

这种现象不仅仅在山东省存在,全国大部分县级中医院及乡镇卫生院,中医专业人才匮乏、服务能力不强的现象普遍存在,仍然是制约中医药在基层发挥作用的瓶颈。

山东省试图突破这种瓶颈。除了培养和选拔优秀人才,打造精英人才队伍、促进优秀人才下沉,也是中医药人才建设工作的重点。山东省不断加强中医药理论方法继承和师承方式继承,使优秀的资源能够向基层倾斜,培养更多的基层人才。

作为齐鲁古代医家学术思想的发源地,集聚着扁鹊、淳于意、王叔和等著名医家理论精华,山东省充分利用这些资源,加强中医药理论方法继承。广泛普及五运六气等中医理论,提升中医药理论指导临床实践的能力,系统总结国医大师、全国名中医和省名中医临床诊疗经验,分享给基层医生。

以中医药学经典传承为主线,以经方技术运用为重点,以经验心得传授为核心,以提高中医药疗效和服务能力为目标,山东省开始推进“三经传承”战略。“学经典、用经方、传经验”,保持和发挥中医药特色和优势,推广中医药技术方法,不断提高全行业中医药从业人员临床实践服务能力,打通从顶层设计到基层建设的通道。

在山东省基层医院的诊室里,名家经典医案堆成小山,医生们随手翻阅查看,这是“三经传承”战略深入推行到基层的一处缩影。未来,山东省还将建设一批“三经传承”研究推广基地,开展“三经传承”远程教育培训,进行经典、经方、经验的推广与普及,并在中医药院校探索建立中医经典等级考试制度。

孙春玲评价道:“这一战略对于基层人才建设有重大意义,受到山东省中医药行业的普遍认可。”

医教协同拓新路

从医科学生到合格医生,中间的路途并不平坦。在临床实践中,不少医生面临着现实病例与书本上的内容千差万别的棘手情况。如何为医学新人创造更多的实践机会是当前要解决的新问题。

一直以来,中医药基层服务面临着人才的岗位胜任力与患者需求不匹配的问题,为满足中医基层医疗卫生建设的需要,医教协同是一剂良方。

2018年,湖北省将继续推进以“5+3”,即5年中医学本科教育+3年中医住院医师规范化培训或3年中医硕士专业学位研究生教育为主体,以“3+2”即3年中医学专科教育+2年中医类别助理全科医生培训为补充的中医临床人才培养,加快推进中医药健康服务技术技能人才培养,建立和完善符合中医药行业特点的人才培养机制。

姚云说:“这有利于形成优秀中医药人才脱颖而出的政策环境和社会氛围,促使湖北省的中医药发展呈现出新的格局。”

十步芳草,济济一堂。一支高层次、多元化的中医药人才队伍正在形成。中医药人才将各尽其能,各展其长,让中医药事业迸发新活力。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1796797, encodeId=24ae1e96797a0, content=<a href='/topic/show?id=490e2149e82' target=_blank style='color:#2F92EE;'>#中医药人才#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21497, encryptionId=490e2149e82, topicName=中医药人才)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fbd46, createdName=mei531, createdTime=Sat Oct 20 00:28:00 CST 2018, time=2018-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796810, encodeId=75de1e9681064, content=<a href='/topic/show?id=0f9f2149803' target=_blank style='color:#2F92EE;'>#中医药人才培养#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21498, encryptionId=0f9f2149803, topicName=中医药人才培养)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=416347, createdName=mhzhuang@stu.e, createdTime=Fri Sep 28 00:28:00 CST 2018, time=2018-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409314, encodeId=135c14093147c, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Fri Jan 26 10:28:00 CST 2018, time=2018-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469585, encodeId=00881469585e1, content=<a href='/topic/show?id=ee4a352e18a' target=_blank style='color:#2F92EE;'>#医药人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35271, encryptionId=ee4a352e18a, topicName=医药人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc517042865, createdName=limedical1976, createdTime=Fri Jan 26 10:28:00 CST 2018, time=2018-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554879, encodeId=4f2315548e9a0, content=<a href='/topic/show?id=023b249083e' target=_blank style='color:#2F92EE;'>#人才培养#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24908, encryptionId=023b249083e, topicName=人才培养)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=056914558248, createdName=jml2014, createdTime=Fri Jan 26 10:28:00 CST 2018, time=2018-01-26, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1796797, encodeId=24ae1e96797a0, content=<a href='/topic/show?id=490e2149e82' target=_blank style='color:#2F92EE;'>#中医药人才#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21497, encryptionId=490e2149e82, topicName=中医药人才)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fbd46, createdName=mei531, createdTime=Sat Oct 20 00:28:00 CST 2018, time=2018-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796810, encodeId=75de1e9681064, content=<a href='/topic/show?id=0f9f2149803' target=_blank style='color:#2F92EE;'>#中医药人才培养#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21498, encryptionId=0f9f2149803, topicName=中医药人才培养)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=416347, createdName=mhzhuang@stu.e, createdTime=Fri Sep 28 00:28:00 CST 2018, time=2018-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409314, encodeId=135c14093147c, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Fri Jan 26 10:28:00 CST 2018, time=2018-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469585, encodeId=00881469585e1, content=<a href='/topic/show?id=ee4a352e18a' target=_blank style='color:#2F92EE;'>#医药人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35271, encryptionId=ee4a352e18a, topicName=医药人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc517042865, createdName=limedical1976, createdTime=Fri Jan 26 10:28:00 CST 2018, time=2018-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554879, encodeId=4f2315548e9a0, content=<a href='/topic/show?id=023b249083e' target=_blank style='color:#2F92EE;'>#人才培养#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24908, encryptionId=023b249083e, topicName=人才培养)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=056914558248, createdName=jml2014, createdTime=Fri Jan 26 10:28:00 CST 2018, time=2018-01-26, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1796797, encodeId=24ae1e96797a0, content=<a href='/topic/show?id=490e2149e82' target=_blank style='color:#2F92EE;'>#中医药人才#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21497, encryptionId=490e2149e82, topicName=中医药人才)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fbd46, createdName=mei531, createdTime=Sat Oct 20 00:28:00 CST 2018, time=2018-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796810, encodeId=75de1e9681064, content=<a href='/topic/show?id=0f9f2149803' target=_blank style='color:#2F92EE;'>#中医药人才培养#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21498, encryptionId=0f9f2149803, topicName=中医药人才培养)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=416347, createdName=mhzhuang@stu.e, createdTime=Fri Sep 28 00:28:00 CST 2018, time=2018-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409314, encodeId=135c14093147c, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Fri Jan 26 10:28:00 CST 2018, time=2018-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469585, encodeId=00881469585e1, content=<a href='/topic/show?id=ee4a352e18a' target=_blank style='color:#2F92EE;'>#医药人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35271, encryptionId=ee4a352e18a, topicName=医药人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc517042865, createdName=limedical1976, createdTime=Fri Jan 26 10:28:00 CST 2018, time=2018-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554879, encodeId=4f2315548e9a0, content=<a href='/topic/show?id=023b249083e' target=_blank style='color:#2F92EE;'>#人才培养#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24908, encryptionId=023b249083e, topicName=人才培养)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=056914558248, createdName=jml2014, createdTime=Fri Jan 26 10:28:00 CST 2018, time=2018-01-26, status=1, ipAttribution=)]
    2018-01-26 hb2008ye
  4. [GetPortalCommentsPageByObjectIdResponse(id=1796797, encodeId=24ae1e96797a0, content=<a href='/topic/show?id=490e2149e82' target=_blank style='color:#2F92EE;'>#中医药人才#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21497, encryptionId=490e2149e82, topicName=中医药人才)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fbd46, createdName=mei531, createdTime=Sat Oct 20 00:28:00 CST 2018, time=2018-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796810, encodeId=75de1e9681064, content=<a href='/topic/show?id=0f9f2149803' target=_blank style='color:#2F92EE;'>#中医药人才培养#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21498, encryptionId=0f9f2149803, topicName=中医药人才培养)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=416347, createdName=mhzhuang@stu.e, createdTime=Fri Sep 28 00:28:00 CST 2018, time=2018-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409314, encodeId=135c14093147c, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Fri Jan 26 10:28:00 CST 2018, time=2018-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469585, encodeId=00881469585e1, content=<a href='/topic/show?id=ee4a352e18a' target=_blank style='color:#2F92EE;'>#医药人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35271, encryptionId=ee4a352e18a, topicName=医药人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc517042865, createdName=limedical1976, createdTime=Fri Jan 26 10:28:00 CST 2018, time=2018-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554879, encodeId=4f2315548e9a0, content=<a href='/topic/show?id=023b249083e' target=_blank style='color:#2F92EE;'>#人才培养#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24908, encryptionId=023b249083e, topicName=人才培养)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=056914558248, createdName=jml2014, createdTime=Fri Jan 26 10:28:00 CST 2018, time=2018-01-26, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1796797, encodeId=24ae1e96797a0, content=<a href='/topic/show?id=490e2149e82' target=_blank style='color:#2F92EE;'>#中医药人才#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21497, encryptionId=490e2149e82, topicName=中医药人才)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fbd46, createdName=mei531, createdTime=Sat Oct 20 00:28:00 CST 2018, time=2018-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796810, encodeId=75de1e9681064, content=<a href='/topic/show?id=0f9f2149803' target=_blank style='color:#2F92EE;'>#中医药人才培养#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21498, encryptionId=0f9f2149803, topicName=中医药人才培养)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=416347, createdName=mhzhuang@stu.e, createdTime=Fri Sep 28 00:28:00 CST 2018, time=2018-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409314, encodeId=135c14093147c, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Fri Jan 26 10:28:00 CST 2018, time=2018-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469585, encodeId=00881469585e1, content=<a href='/topic/show?id=ee4a352e18a' target=_blank style='color:#2F92EE;'>#医药人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35271, encryptionId=ee4a352e18a, topicName=医药人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc517042865, createdName=limedical1976, createdTime=Fri Jan 26 10:28:00 CST 2018, time=2018-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554879, encodeId=4f2315548e9a0, content=<a href='/topic/show?id=023b249083e' target=_blank style='color:#2F92EE;'>#人才培养#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24908, encryptionId=023b249083e, topicName=人才培养)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=056914558248, createdName=jml2014, createdTime=Fri Jan 26 10:28:00 CST 2018, time=2018-01-26, status=1, ipAttribution=)]

相关资讯

“中医文化与养生之道”悉尼开讲!海外民众也这么喜欢中医药

悉尼中国文化中心邀专家传播中医药健康文化19日举办“中医文化与养生之道”讲座。中国北京中医药大学副教授、澳大利亚西悉尼大学中澳中医中心负责人黄青博士担任主讲人,以“中医皮肤护理与养生精要”为题,增进澳大利亚民众对中医药的了解,从而传播中华优秀传统文化。

国外青睐中国中医药的“世界记忆”

抗疟药物“青蒿素”挽救全球数百万人生命,“中医针灸”列入联合国教科文组织人类非物质文化遗产代表作名录并传遍全世界100多个国家,《黄帝内经》和《本草纲目》入选世界记忆名录……当下中医药“国际范”十足,在造福全球人类健康事业上大放异彩!

王国强:突出中医药特色优势,培养高素质临床人才

1月20日至21日,国家卫生计生委副主任、国家中医药管理局局长王国强就中医临床人才培养深入江苏开展专题调研,强调要以习近平新时代中国特色社会主义思想为指导,深入贯彻全国中医药工作会议精神,实施好中医药传承与创新“百千万”人才工程,坚持分类指导,突出建设重点,弘扬医德医风,为传承发展中医药事业提供坚实人才支撑。

河南:找准5个着力点加强中医药文化建设

近日,河南省中医管理局、河南省文化厅印发《关于加强中医药文化建设的指导意见》,明确通过5项主要任务,加强中医药文化建设,提出要通过5~10年,基本建立中医药文化建设有效机制,中医药健康文化素养水平较“十三五”初期提升10%。

中医药领域五年多荣获41项国家科技奖励

近日从国家中医药管理局相关负责人表示,党的十八大以来,中医药领域荣获国家科技奖励41项,其中国家科技进步一等奖6项,我国传统医学科技创新不断取得突破。

上海:推进中医药全面融入家庭医生签约服务

上海始终坚持“中医药融入社区,服务基层”,在基本实现中医药融入基本公共卫生服务与管理的基础上,积极稳妥推进中医药融入家庭医生服务,落实中医药参与分级诊疗制度建设,取得初步成效。

Baidu
map
Baidu
map
Baidu
map